Yiming Yang

China Japan Union Hospital Of Jilin University
Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.

Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.

Journal: Frontiers in pharmacology

Published: November 22, 2024

Exploring the therapeutic potential and in vitro validation of baicalin for the treatment of triple-negative breast cancer.

Exploring the therapeutic potential and in vitro validation of baicalin for the treatment of triple-negative breast cancer.

Journal: Frontiers in pharmacology

Published: November 19, 2024

Characteristics and advances in signaling pathways, cellular communication, cell junctions, and oxidative stress in lymphedema.

Characteristics and advances in signaling pathways, cellular communication, cell junctions, and oxidative stress in lymphedema.

Journal: Frontiers in cell and developmental biology

Published: November 04, 2024

Cancer-Related Therapeutic Potential of Epimedium and Its Extracts.

Cancer-Related Therapeutic Potential of Epimedium and Its Extracts.

Journal: Nutrition and cancer

Published: July 27, 2024

Anti-inflammatory effects of steroidal alkaloids of Solanum lyratum Thunb.

Anti-inflammatory effects of steroidal alkaloids of Solanum lyratum Thunb.

Journal: Pakistan journal of pharmaceutical sciences

Published: June 01, 2024

TRPML1 acts as a predisposing factor in lymphedema development by regulating the subcellular localization of aquaporin-3, -5.

TRPML1 acts as a predisposing factor in lymphedema development by regulating the subcellular localization of aquaporin-3, -5.

Journal: PloS one

Published: April 27, 2024

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies.

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies.

Journal: Frontiers in immunology

Published: February 13, 2024

TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review.

TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review.

Journal: Frontiers in oncology

Published: October 22, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026